DK3360895T3 - Præparat omfattende faktor-viii og von-willebrand-faktor-peptider - Google Patents
Præparat omfattende faktor-viii og von-willebrand-faktor-peptider Download PDFInfo
- Publication number
- DK3360895T3 DK3360895T3 DK18159816.0T DK18159816T DK3360895T3 DK 3360895 T3 DK3360895 T3 DK 3360895T3 DK 18159816 T DK18159816 T DK 18159816T DK 3360895 T3 DK3360895 T3 DK 3360895T3
- Authority
- DK
- Denmark
- Prior art keywords
- von
- peptides
- preparation including
- factor
- willebrand
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14171579 | 2014-06-06 | ||
| EP15732554.9A EP3152230B1 (en) | 2014-06-06 | 2015-06-08 | Preparation comprising factor viii and von willebrand factor peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3360895T3 true DK3360895T3 (da) | 2021-11-15 |
Family
ID=50884302
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15732554T DK3152230T3 (da) | 2014-06-06 | 2015-06-08 | Præparat omfattende faktor viii og von willebrand-faktor-peptider |
| DK18159816.0T DK3360895T3 (da) | 2014-06-06 | 2015-06-08 | Præparat omfattende faktor-viii og von-willebrand-faktor-peptider |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15732554T DK3152230T3 (da) | 2014-06-06 | 2015-06-08 | Præparat omfattende faktor viii og von willebrand-faktor-peptider |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10251940B2 (da) |
| EP (2) | EP3152230B1 (da) |
| JP (1) | JP6605593B2 (da) |
| KR (1) | KR20170010895A (da) |
| CN (1) | CN106414492B (da) |
| AU (1) | AU2015270394B2 (da) |
| BR (1) | BR112016026842A2 (da) |
| CA (1) | CA2949323A1 (da) |
| DK (2) | DK3152230T3 (da) |
| ES (2) | ES2895798T3 (da) |
| IL (1) | IL249294A0 (da) |
| RU (1) | RU2714154C2 (da) |
| WO (1) | WO2015185758A2 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2018128582A (ru) | 2016-01-07 | 2020-02-11 | Цсл Беринг Ленгнау Аг | Мутированный укороченный фактор фон виллебранда |
| CN109152817A (zh) | 2016-05-20 | 2019-01-04 | 瑞士奥克特珐玛公司 | 具有改进的药代动力学的糖基化vwf融合蛋白 |
| EP3538134B1 (en) | 2016-11-11 | 2021-12-29 | CSL Behring Lengnau AG | Truncated von willebrand factor polypeptides for extravascular administration in the treatment or prophylaxis of a blood coagulation disorder |
| CA3068098A1 (en) | 2017-06-22 | 2018-12-27 | CSL Behring Lengnau AG | Modulation of fviii immunogenicity by truncated vwf |
| TW202015723A (zh) | 2018-05-18 | 2020-05-01 | 美商百歐維拉提夫治療公司 | 治療ａ型血友病的方法 |
| WO2021001522A1 (en) | 2019-07-04 | 2021-01-07 | CSL Behring Lengnau AG | A truncated von willebrand factor (vwf) for increasing the in vitro stability of coagulation factor viii |
| EP4013389A1 (en) | 2019-08-16 | 2022-06-22 | Octapharma AG | Stabilizing buffer for factor viii and vwf |
| WO2024200652A1 (en) | 2023-03-31 | 2024-10-03 | Octapharma Ag | Fviii-vwf fusion proteins with improved pharmacokinetics |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE504074C2 (sv) | 1993-07-05 | 1996-11-04 | Pharmacia Ab | Proteinberedning för subkutan, intramuskulär eller intradermal administrering |
| IL113010A0 (en) | 1994-03-31 | 1995-10-31 | Pharmacia Ab | Pharmaceutical formulation comprising factor VIII or factor ix with an activity of at least 200 IU/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration |
| AU2008261261B2 (en) | 2007-06-13 | 2013-06-27 | Csl Behring Gmbh | Use of VWF stabilized FVIII preparations and of VWF preparations without FVIII for extravascular administration in the therapy and prophylactic treatment of bleeding disorders |
| ES2298096B1 (es) * | 2008-01-08 | 2009-01-01 | Grifols, S.A. | Procedimiento para la obtencion de un concentrado de factor von willebrand o del complejo de factor viii/factor von willebrand y utilizacionde los mismos. |
| RU2011110459A (ru) | 2008-08-21 | 2012-09-27 | Октафарма АГ (CH) | Рекомбинантно полученный человеческий фактор viii и ix |
| AU2010284977A1 (en) | 2009-08-20 | 2012-03-29 | Csl Behring Gmbh | Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders |
| CA2771232A1 (en) * | 2009-08-20 | 2011-02-24 | Baxter International Inc. | Purification of vwf for increased removal of non-lipid enveloped viruses |
| KR20140083036A (ko) | 2011-10-18 | 2014-07-03 | 체에스엘 베링 게엠베하 | 인자 ｖｉｉｉ의 생체이용률을 향상시키기 위한 황산화 글리코사미노글리칸의 용도 |
| US20150080309A1 (en) * | 2012-04-24 | 2015-03-19 | Nova Nordisk A/S | Compounds Suitable for Treatment of Haemophilia |
| US20150045303A1 (en) * | 2012-04-24 | 2015-02-12 | Novo Nordisk A/S | Pharmaceutical Composition Suitable for Treatment of Haemophilia |
-
2015
- 2015-06-08 WO PCT/EP2015/062730 patent/WO2015185758A2/en active Application Filing
- 2015-06-08 RU RU2016152151A patent/RU2714154C2/ru active
- 2015-06-08 EP EP15732554.9A patent/EP3152230B1/en active Active
- 2015-06-08 BR BR112016026842A patent/BR112016026842A2/pt not_active Application Discontinuation
- 2015-06-08 CA CA2949323A patent/CA2949323A1/en not_active Abandoned
- 2015-06-08 ES ES18159816T patent/ES2895798T3/es active Active
- 2015-06-08 CN CN201580029649.9A patent/CN106414492B/zh active Active
- 2015-06-08 KR KR1020177000328A patent/KR20170010895A/ko not_active Application Discontinuation
- 2015-06-08 DK DK15732554T patent/DK3152230T3/da active
- 2015-06-08 US US15/316,711 patent/US10251940B2/en active Active
- 2015-06-08 EP EP18159816.0A patent/EP3360895B1/en active Active
- 2015-06-08 DK DK18159816.0T patent/DK3360895T3/da active
- 2015-06-08 ES ES15732554T patent/ES2747815T3/es active Active
- 2015-06-08 AU AU2015270394A patent/AU2015270394B2/en active Active
- 2015-06-08 JP JP2017516207A patent/JP6605593B2/ja active Active
-
2016
- 2016-11-30 IL IL249294A patent/IL249294A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2015270394A1 (en) | 2016-11-24 |
| RU2016152151A (ru) | 2018-07-10 |
| EP3360895A3 (en) | 2018-10-17 |
| CN106414492A (zh) | 2017-02-15 |
| WO2015185758A3 (en) | 2016-02-11 |
| ES2747815T3 (es) | 2020-03-11 |
| WO2015185758A2 (en) | 2015-12-10 |
| RU2714154C2 (ru) | 2020-02-12 |
| CA2949323A1 (en) | 2015-12-10 |
| AU2015270394B2 (en) | 2017-12-21 |
| EP3360895B1 (en) | 2021-08-11 |
| EP3152230B1 (en) | 2019-08-07 |
| US10251940B2 (en) | 2019-04-09 |
| IL249294A0 (en) | 2017-02-28 |
| EP3360895A2 (en) | 2018-08-15 |
| DK3152230T3 (da) | 2019-11-11 |
| KR20170010895A (ko) | 2017-02-01 |
| RU2016152151A3 (da) | 2019-02-06 |
| EP3152230A2 (en) | 2017-04-12 |
| ES2895798T3 (es) | 2022-02-22 |
| JP2017518376A (ja) | 2017-07-06 |
| CN106414492B (zh) | 2021-07-06 |
| BR112016026842A2 (pt) | 2017-12-12 |
| JP6605593B2 (ja) | 2019-11-13 |
| US20180185455A1 (en) | 2018-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3157552T3 (da) | Syntac-polypeptider og anvendelser deraf | |
| DK3091997T5 (da) | Kimære faktor viii-proteiner og anvendelser deraf | |
| DK3412302T3 (da) | Modificerede fgf-21-polypeptider og anvendelser deraf | |
| DK3229838T3 (da) | Anti-C10orf54-antistoffer og anvendelser deraf | |
| DK3268470T3 (da) | Transposasepolypeptider og anvendelser deraf | |
| DK3126388T3 (da) | Anti-EGFRvIII-antistoffer og anvendelser deraf | |
| DK3235830T3 (da) | Interleukin-15-proteinkompleks og anvendelse deraf | |
| DK3227342T4 (da) | Proteinøs heterodimer og anvendelse deraf | |
| DK3212255T3 (da) | Selvorienterende sprøjte og sprøjtegrænseflade | |
| DK3210977T3 (da) | Hidtil ukendt aminoalkylbenzothiazepinderivat og anvendelse deraf | |
| DK3224603T3 (da) | Nordning og fremgangsmåde til materialekarakteristik | |
| DK3218358T3 (da) | Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner | |
| DK4089113T3 (da) | Polypeptider | |
| DK3498292T3 (da) | Uspa2-proteinkonstruktioner og anvendelser deraf | |
| DK3018183T3 (da) | Halogenolefinbaseret sammensætning og anvendelse deraf | |
| DK3723783T3 (da) | Mitokondrie-målrettede peptider | |
| DK3169703T3 (da) | Kimær antigenreceptor og anvendelse deraf | |
| DK3116911T3 (da) | Anti-mcam-antistoffer og tilhørende fremgangsmåder til anvendelse | |
| DK3114141T3 (da) | Insulinlignende vækstfaktor 1-receptor-specifikke antistoffer og anvendelse deraf | |
| DK3161139T3 (da) | Tlr-4-specifikke aptamerer og anvendelser heraf | |
| DK3360895T3 (da) | Præparat omfattende faktor-viii og von-willebrand-faktor-peptider | |
| DK3233903T3 (da) | Kimære antigenreceptorer og anvendelsesfremgangsmåder | |
| DK3209773T3 (da) | Prolintolerante tripeptidylpeptidaser og anvendelser deraf | |
| DK3100050T3 (da) | Immobiliserede proteiner og anvendelse deraf | |
| DK3099791T3 (da) | Protein |